Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
Apply
IFx-Hu2.0 & Pembrolizumab
IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step